USPTO serial 79430633
NEUROSOMIX
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- JACKSON, MARISSA SHARPE
- Law office
- TMO LAW OFFICE 113
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with NEUROSOMIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for analyses in laboratories, except for medical or veterinary use; chemical reagents, except for medical or veterinary purposes; diagnostic preparations and reagents, except for medical or veterinary use; chemical diagnostic preparations for scientific purposes; diagnostic scanning agents for in vivo scientific use; diagnostic preparations for clinical diagnostic use, except for medical or veterinary use; diagnostic kits comprising sample receptors, synthetic antibody-like bioreceptors for the detection of biomarkers related oncology and reagents for analyzing selected bacteria, except for medical or veterinary use; diagnostic test materials, except for medical use, namely, diagnostic preparations for in vitro testing for scientific use; chemical preparations for use in immunoassay testing, except for medical or veterinary use; immunoassay reagents, except for medical or veterinary use. | ACTIVE | — |
| 005 | Skin cleansing preparations for medical use; biological preparations for use in cell cultures for medical purposes; chemical preparations for medical use, namely, for the treatment and detection of cancer; chemico-pharmaceutical preparations for the treatment and detection of cancer; diagnostic preparations for medical use; chemical reagents for medical or veterinary use; diagnostic reagents for medical use; reagents for clinical diagnosis for medical use; reagents for clinical analysis for medical use; reagents with biomarkers for medical diagnostics; immunoassay reagents for medical use; diagnostic test materials for medical use, namely, diagnostic test reagents for medical use | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, in vitro diagnostic devices for the detection, assessment, evolution and response to treatment of diseases based on the analysis of biomarkers in extracellular vesicles derived from neurons; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the detection, assessment, evolution, and tracking of the response to treatment of cancerous diseases based on analysis of biomarkers in extracellular vesicles derived from cancer; detector apparatus for medical use in diagnostics, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the detection, assessment, evolution, and tracking of the response to treatment of cancerous diseases based on analysis of biomarkers in extracellular vesicles derived from cancer; diagnostic testing apparatus for medical purposes for detecting cancer; medical equipment for diagnosis, examination, and monitoring in the form of respiratory equipment and monitors for the same; tools for medical diagnostics, namely, medical devices and surgical instruments for use in diagnosis and surgery of the gastrointestinal tract; medical diagnostic instruments for the analysis of bodily fluids; testing instruments for medical diagnostic use in the form of ultrasonic medical diagnostic apparatus; medical diagnostic instruments for use in immunoassay procedures, such as immunochemical medical diagnostic apparatus for detecting and measuring antibody levels; immunological analyzers such as immunochemical testing apparatus for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 11, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 7, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 13, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 21, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |